Zephyrus

Zephyrus The Zephyrus 2 study is evaluating pamrevlumab, an investigational drug, in patients with idiopathic pulmonary fibrosis (IPF).

The clinical trial aims to determine the efficacy and safety of a possible IPF treatment.

11/15/2022
06/28/2022

Address

FibroGen, Inc. 409 Illinois Street
San Francisco, CA
94158

Website

Alerts

Be the first to know and let us send you an email when Zephyrus posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Zephyrus:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category